Mechanisms of disease: Leukotrienes

被引：877

作者：

Peters-Golden, Marc

Henderson, William R., Jr.

机构：

[1] Univ Michigan Hlth Syst, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA

[2] Univ Washington, Dept Med, Div Allergy & Infect Dis, Ctr Allergy & Inflammat, Seattle, WA USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2007年 / 357卷 / 18期

关键词：

D O I：

10.1056/NEJMra071371

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This review of leukotrienes, which are lipid mediators with a broad array of clinical effects, and leukotriene receptors considers the biochemical and physiological aspects of these molecules, examines their roles in asthma and other diseases, and explains the pharmacologic effects of antileukotriene agents. Copyright © 2007 Massachusetts Medical Society.

引用

收藏

页码：1841 / 1854

页数：14

相关论文

共 123 条

[1] Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice [J].

Aiello, RJ ;

Bourassa, PA ;

Lindsey, S ;

Weng, WF ;

Freeman, A ;

Showell, HJ .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (03) :443-449

[2]

[Anonymous], 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003133

[3] Leukotriene C4 synthase gene A(-444)C polymorphism and clinical response to a CYS-LT1 antagonist, pranlukast, in Japanese patients with moderate asthma [J].

Asano, K ;

Shiomi, T ;

Hasegawa, N ;

Nakamura, H ;

Kudo, H ;

Matsuzaki, T ;

Hakuno, H ;

Fukunaga, K ;

Suzuki, Y ;

Kanazawa, M ;

Yamaguchi, K .

PHARMACOGENETICS, 2002, 12 (07) :565-570

[4] Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling [J].

Avis, IM ;

Jett, M ;

Boyle, T ;

Vos, MD ;

Moody, T ;

Treston, AM ;

Martinez, A ;

Mulshine, JL .

JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (03) :806-813

[5] Leukotriene B4 signaling through NF-κB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia [J].

Bäck, M ;

Bu, DX ;

Bränström, R ;

Sheikine, Y ;

Yan, ZQ ;

Hansson, GK .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (48) :17501-17506

[6] The national montelukast survey [J].

Barnes, N ;

Thomas, M ;

Price, D ;

Tate, H .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 115 (01) :47-54

[7] Induction of hepatic microsomal drug-metabolizing enzymes by inhibitors of 5-lipoxygenase (5-LO): Studies in rats and 5-LO knockout mice [J].

Beierschmitt, WP ;

McNeish, JD ;

Griffiths, RJ ;

Nagahisa, A ;

Nakane, M ;

Amacher, DE .

TOXICOLOGICAL SCIENCES, 2001, 63 (01) :15-21

[8] Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycin-induced pulmonary fibrosis in mice [J].

Beller, TC ;

Maekawa, A ;

Friend, DS ;

Austen, KF ;

Kanaoka, Y .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (44) :46129-46134

[9] Zileuton: clinical implications of 5-Lipoxygenase inhibition in severe airway disease [J].

Berger, W. ;

De Chandt, M. T. M. ;

Cairns, C. B. .

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (04) :663-676

[10] Structural changes in airway diseases - Characteristics, mechanisms, consequences, and pharmacologic modulation [J].

Bergeron, C ;

Boulet, LP .

CHEST, 2006, 129 (04) :1068-1087

← 1 2 3 4 5 6 7 8 9 10 →